- Drugs
- Monday, 04 May 2020
Pharmaceutics International Selected as A Winner of Two GH&P Awards
Pharmaceutics International, Inc. (Pii), a US-based Contract Development and Manufacturing Organization (CDMO) today announced it has won the 2020 CDMO Leadership Award and was named the Most Innovative Company in Dosage Solutions by Global Health & Pharma Magazine.
"We are honored to be recognized in these two categories. Pii has an extensive range of technologies, skilled personnel and Pharmaceutics Know-How™, to enable the rapid development and reliable production of high-quality sterile and oral dosage forms. It is extremely gratifying to have our innovation, accomplishments and commitment to partners and patients acknowledged," said Dr. Kurt R. Nielsen, Pii's President and CEO.
According to GH&P, "Biotechnology is a huge, varied and ever-growing industry. Operating and succeeding in such an environment which, in many ways, demands excellence at every turn is - it goes without saying - incredibly difficult, yet there are businesses that have learned to thrive under such conditions. To harness innovation and deliver results, driving the greater industry onwards." Jazmin Collins, GH&P Awards Coordinator, commented "Regardless of their size or location, we honor companies from across this vibrant and talented sector."
Related Industry Updates
India will ship nearly 1,000 tonnes of paracetamol raw material to Europe
May 06, 2020
See how South Africa Anti-Infective Market is Changes during 2019-2027 with an increase in Revenue of $2572.5Mn| Sanofi, Abbott, Pfizer
Oct 27, 2020
FDA Approves Harmony Biosciences' Sleep Disorder Drug
Sep 04, 2019
CIN and HR-HPV Treatment Market is expected to reach US$ 17,164.61 million by 2028
May 10, 2023
Antifungal Drugs Market is expected to reach US$ 13,997.4 Million in 2028
Jan 16, 2023
Myopia Treatment Market is expected to reach US$ 19,571.85 million by 2030
Jan 10, 2024
CaaMTech Collaborates With National Institutes of Health to Research Psychedelics
May 08, 2020